
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
NEUESTE BEITRÄGE
- 1
What is colostrum? And should you be taking it?15.11.2025 - 2
Roman around the Christmas tree | Space photo of the day for Dec. 25, 202525.12.2025 - 3
David Duchovny's new thriller has him stripping down at 65. But its chilling premise hits close to home.14.11.2025 - 4
At least 30 killed in attack on Nigeria village04.01.2026 - 5
Polar bears are rewiring their own genetics to survive a warming climate12.12.2025
Ähnliche Artikel
'Peaky Blinders: The Immortal Man' teaser trailer reveals Cillian Murphy's Tommy Shelby back in action24.12.2025
Well known SUVs With Low Energy Utilization In 202405.06.2024
Herzog, German Chancellor Merz discuss final Gaza hostage, Arrow 3 exchange in Jerusalem06.12.2025
Find the Mysteries of Effective Objective Setting: Transforming Dreams into Feasible Targets14.07.2023
Top 10 Moving Style Architects of the Year07.07.2023
4 injured in shooting at North Carolina tree lighting ceremony22.11.2025
Misremembering might actually be a sign your memory is working optimally05.12.2025
One perk to marrying Richard Marx later in life? 'We don't have time' for stupid arguments, says Daisy Fuentes.27.11.2025
Rights group: At least 2,500 deaths during protest crackdown in Iran13.01.2026
5 Signs Now is the ideal time to Update Your Android Telephone: When to Take the Action30.06.2023













